Paper39883227
Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment.
Abulsoud AI and 12 others. Med Oncol, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment. Papers, record 39883227. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39883227
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Urinary Bladder Neoplasms | Major topic |
| Biological Products | Major topic |
| Humans | |
| Animals | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
References105
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38707615 | Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/38707615 | PubMed |
| 2 | 25533674 | Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/25533674 | PubMed |
| 3 | 35778656 | miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway. | Discov Oncol | 2022 | https://conductscience.org/library/papers/35778656 | PubMed |
| 4 | 25469061 | Prevalence and risk factors for depression in Korean adult patients with asthma: is there a difference between elderly and non-elderly patients? | J Korean Med Sci | 2014 | https://conductscience.org/library/papers/25469061 | PubMed |
| 5 | 38563878 | Unveiling the pharmacological potential of plant triterpenoids in breast cancer management: an updated review. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | https://conductscience.org/library/papers/38563878 | PubMed |
| 6 | 19519535 | Ras-MAPK pathway as a therapeutic target in cancer--emphasis on bladder cancer. | Recent Pat Anticancer Drug Discov | 2009 | https://conductscience.org/library/papers/19519535 | PubMed |
| 7 | 24490857 | Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24490857 | PubMed |
| 8 | 34800653 | Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatment. | Crit Rev Oncol Hematol | 2021 | https://conductscience.org/library/papers/34800653 | PubMed |
| 9 | 21836020 | Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. | Cancer Prev Res (Phila) | 2011 | https://conductscience.org/library/papers/21836020 | PubMed |
| 10 | 23159064 | Epithelial-mesenchymal transition, a novel target of sulforaphane via COX-2/MMP2, 9/Snail, ZEB1 and miR-200c/ZEB1 pathways in human bladder cancer cells. | J Nutr Biochem | 2013 | https://conductscience.org/library/papers/23159064 | PubMed |
| 11 | 39003425 | Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges. | Drug Deliv Transl Res | 2024 | https://conductscience.org/library/papers/39003425 | PubMed |
| 12 | 26660324 | Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development? | J Cancer Res Clin Oncol | 2016 | https://conductscience.org/library/papers/26660324 | PubMed |
| 13 | 30070321 | MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2. | Eur Rev Med Pharmacol Sci | 2018 | https://conductscience.org/library/papers/30070321 | PubMed |
| 14 | 39022680 | Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/39022680 | PubMed |
| 15 | 31878082 | Quercetin, Epigallocatechin Gallate, Curcumin, and Resveratrol: From Dietary Sources to Human MicroRNA Modulation. | Molecules | 2019 | https://conductscience.org/library/papers/31878082 | PubMed |
| 16 | 28069380 | microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28069380 | PubMed |
| 17 | 38105263 | Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/38105263 | PubMed |
| 18 | 31612063 | MicroRNA-34a inhibits bladder cancer cell migration and invasion, and upregulates PTEN expression. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31612063 | PubMed |
| 19 | 30412716 | Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis. | Exp Cell Res | 2019 | https://conductscience.org/library/papers/30412716 | PubMed |
| 20 | 30149755 | Curcumin Suppresses microRNA-7641-Mediated Regulation of p16 Expression in Bladder Cancer. | Am J Chin Med | 2018 | https://conductscience.org/library/papers/30149755 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41682926 | Intersection of Precision Nutrition and Bladder Cancer: A Narrative State-of-the-Art Review of Potential Applications and Challenges. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682926 | PubMed |
| 41668793 | Harnessing natural compounds and nanotechnology for miRNA-based osteosarcoma therapy. | RSC Adv | 2026 | https://conductscience.org/library/papers/41668793 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39883227
GET https://conductscience.org/api/papers/v1/39883227/references?page=2